In The News Posted March 17, 2021 Share Posted March 17, 2021 TAMPA, Fla., March 17, 2021 /PRNewswire/ -- M2GEN, a leading oncology-focused data and informatics company, announced today a significant new five-year agreement with Merck, known as MSD outside the United States and Canada. Under the terms of the agreement, M2GEN will provide valuable...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.